Eisai Co., Ltd. et al v. MSN Pharmaceuticals Inc. > Summary
Court Case Number 1:20-cv-00791
Filing Date Jun 10, 2020
Termination Date Oct 15, 2020
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesLeonard P. Stark
Defendant
Plaintiff Attorneys
9Eisai Co., Ltd.
Attorney Name: Bruce M. Wexler
Paul Hastings
Eisai Co., Ltd.
Attorney Name: Melanie R. Rupert
Paul Hastings
Eisai Co., Ltd.
Attorney Name: Young J. Park
Paul Hastings
Eisai Co., Ltd.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Eisai Co., Ltd.
Attorney Name: Anthony D. Raucci
Morris Nichols Arsht & Tunnell
Eisai Co., Ltd.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Eisai Co., Ltd.
Attorney Name: Anthony D. Raucci
Morris Nichols Arsht & Tunnell
NOVARTIS PHARMA AG
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
NOVARTIS PHARMA AG
Attorney Name: Anthony D. Raucci
Morris Nichols Arsht & Tunnell
Defendant Attorneys
MSN Pharmaceuticals Inc.
Attorney Name: Touhey Myer
Offit Kurman
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 06740669 | Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic | May 25, 2004 |
